Abstract
We conducted a seroepidemiological nested case-control study to determine the association of gastriccancer with Helicobacter pylori infection and atrophicgastritis. A cohort of 2858 participants in an annual multiphasic health check-up werefollowed for eight years. Data for 45 gastric cancercases and 225 sex-, age-, and address-matched controlsubjects were analyzed. Helicobacter pylori infectionwas determined by IgG antibodies, and atrophicgastritis was diagnosed by both serum pepsinogen I level(≤70 ng/ml) and the pepsinogen I/II ratio (≤3.0).Univariate analysis showed that Helicobacter pylori and atrophic gastritis were significantlyassociated with gastric cancer. In a multivariateanalysis, atrophic gastritis was associated withsignificantly increased risk of cancer (odds ratio,3.38; 95% confidence interval, 1.54-7.42); however,Helicobacter pylori was not associated with cancer (oddsratio, 1.84; 95% confidence interval, 0.59-5.72). Theseresults suggest that Helicobacter pylori infection alone is not directly associated with gastriccarcinogenesis but has an indirect relation to gastriccancer through the development of atrophicgastritis.
REFERENCES
Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131, 1991
Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ: Helicobacter pylori infection and gastric carcinoma among Japanese American in Hawaii. N Engl J Med 325:1132–1136, 1991
Forman D, Newell DG, Fullerton F, Yarnell JWG, Stacey AR, Wald N, Sitas F: Association between infection with Helico-bacter pylori and risk of gastric cancer: Evidence from a prospective in vestigation. BMJ 302:1302–1305, 1991
Parsonnet J, Samloff IM, Nelson LM, Orentreich N, Vogelman JH, Friedman GD: Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2:461–466, 1993
Lin JT, Wang LY, Wang JT, Wang TH, Yang CS, Chen CJ: A nested case-control study on the association between Helico-bacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan. Anticancer Res 15:606–606, 1995
Aromaa A, Kosuunen TU, Kenekt P, Maatela J, Teppo L, Heinonen OP, Harkonen M, Hakama MK: Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol 144:142–149, 1996
Hasson LE, Engstrand L, Nyren O, Evans DJ Jr, Lindgren A, Bergstrom R, Andersson B, Athlin L, Bendtsen O, Tracz P: Helicobacter pylori infection: Independent risk indicator of gastric adenocarcinoma. Gastroenterology 105:1098–1103, 1993
Blaser MJ, Kobayashi K, Cover TL, Cao P, Feurer ID, Perez-Perez GI: Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach. Int J Cancer 55:799–802, 1993
Fukuda H, Saito D, Hayashi S, Hisai H, Ono H, Yoshida S, Oguro Y, Noda T, Sato T, Katoh M, Terada M, Sugimura T: Helicobacter pylori infection, serum pepsinogen level and gastric cancer: A case-control study in Japan. Jpn J Cancer Res 86:64–71, 1995
Asaka M, Kimura T, Kato M, Kudo M, Miki K, Ogoshi K, Kato T, Tatsuta M, Graham DY: Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 73:2691–2694, 1994
Kikuchi S, Wada O, Nakajima T, Nishi T, Kobayashi O, Konishi T, Inaba Y: Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Cancer 75:2789–2793, 1995
Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann N, Nomura A: Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55:2111–2115, 1995
Tsugane S, Kabuto M, Imai H, Gey F, Tei Y, Hanaoka T, Sugano K. Watanabe S: Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes Control 4:297–305, 1993
Fukao A, Komatsu S, Tsubono Y, Hisamichi S, Ohori H, Kizawa T, Ohsato N, Fujino N, Endo N, Iha M: Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: A cross-sectional study. Cancer Causes Control 4:307–312, 1993
Kato I, Tominaga S, Ito Y, Kobayashi S, Yoshii Y, Matsuura A, Kameya A, Kano T: Atrophic gastritis and stomach cancer risk: Cross-sectional analyses. Jpn J Cancer Res 83:1041–1046, 1992
Tatsuta M, Nishi H, Nakaizumi A, Okuda S, Taniguchi H, Hiyama T, Tsukuma H, Oshima A: Fundal atrophic gastritis as a risk factor for gastric cancer: Int J Cancer 53:70–74, 1993
Kudo M, Kato M, Meguro T, Kimura M, Asaka M, Miyazaki T: Measurement of antibody to Helicobacter pylori by enzyme immunoassay. Shinyaku to Rinsho 42:2581–2584, 1993 (in Japanese)
Yamamoto K, Fukuda Y, Mizuta T, Sakagami T, Takami S, Tonokatsu Y, Tamura K, Shimoyama T: Evaluation of nine commercial serodiagnostic kits for detection of Helicobacter pylori infection in Japan. Res Forum Dig Dis 1:75–85, 1994 (in Japanese with English abstract)
Ichinose M, Miki K, Furihata C: Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. Clin Chim Acta 126:183–191, 1982
Miki K, Ichinose M: Chronic atrophic gastritis and serum pepsinogen levels. Jpn J Cancer Clin 38:221–229, 1992 (in Japanese with English abstract)
Miki K, Ichinose M, Yahagi N, Tsukuda S, Sano J, Kakei N, Matsushima M, Wada T, Tsuji M, Ishihara S, Shimizu Y, Kurokawa K: Mass screening for gastric cancer with serum pepsinogen test in human dry dock (stomach dry dock). Kenkoigaku 8(1):1–7, 1993 (in Japanese)
Rights and permissions
About this article
Cite this article
Watanabe, Y., Kurata, J.H., Mizuno, S. et al. Helicobacter pylori Infection and Gastric Cancer (A Nested Case-Control Study in a Rural Area of Japan). Dig Dis Sci 42, 1383–1387 (1997). https://doi.org/10.1023/A:1018833819860
Issue Date:
DOI: https://doi.org/10.1023/A:1018833819860